Who owns the SL-NAD+ trademark?

The SL-NAD+ trademark is owned by iX Biopharma Ltd..

What class is the SL-NAD+ trademark registered in?

The SL-NAD+ trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for SL-NAD+?

The USPTO serial number for SL-NAD+ is 79442095.

What is the registration number for SL-NAD+?

SL-NAD+ is registered under USPTO registration number 8481281.

Sealvo

Home Search: SL-NAD+SL-NAD+ #79442095

Back

Updated Oct 6, 2026·39 searches this week

View on USPTO TSDR Find similar marks

SLN

USPTO Trademark Record

REGISTERED

SL-NAD+

SN 79442095·Reg 8481281·Filed Dec 19, 2025

Owner iX Biopharma Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SL-NAD+ (Serial No. 79442095), Registration No. 8481281, is a registered US trademark filed on Dec 19, 2025 by iX Biopharma Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: October 06, 2032

Mark Intelligence

SL-NAD+ (Reg. #8481281) is a registered US trademark that has been protecting its owner, iX Biopharma Ltd., since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 19, 2025

SERIAL

79442095

REG#

8481281

REGISTERED

Oct 06, 2026

Filing Information

StatusREGISTERED

Filing DateDec 19, 2025

Serial Number79442095

Registration No.8481281

Registration DateOct 06, 2026

Status DateOct 06, 2026

Published for OppositionAug 18, 2026

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

20 events

REGISTERED-PRINCIPAL REGISTER

Oct 06, 2026

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Aug 18, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 18, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 12, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 22, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 17, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 17, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 17, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 16, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 16, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 16, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jul 16, 2026

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jun 29, 2026

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 29, 2026

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 10, 2026

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

May 08, 2026

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 22, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 26, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Jan 26, 2026

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jan 22, 2026

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by iX Biopharma Ltd.

Additional USPTO filings from the same owner.

WAF

WAFERMINE

79165545

IX BIOPHARMA LTD.

REGISTERED

WAF

WAFERIX

86725097

iX Biopharma Ltd,

REGISTERED

WAF

WAFERLOGIX

79377279

iX Biopharma Ltd

REGISTERED

GLU

GLUTA-E

79345574

IX BIOPHARMA LTD.

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

NAD

NAD+

87050881

BIONADRX HOLDINGS, INC.

REGISTERED

75455411

Hebra Enterprise, Inc.

REGISTERED

NAD

NAD+ COMPLETE

99571577

RENUE BY SCIENCE INC.

REGISTERED

HOM

HOMEPALS NAD+

99650136

HONGKONG SKETIER TECHNOLOGY LIMITED

REGISTERED

Other Marks by Theodore R. Remaklus

Additional USPTO filings handled by the same attorney of record.

BLK

BLK BLKSMITH

99254852

REGISTERED

HYD

HYDROBEATZ

99283962

97882166

SNOW

88975033

REGISTERED

SL-NAD+

Run a conflict check

Other Marks by iX Biopharma Ltd.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Theodore R. Remaklus

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company